Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/28771
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
Metadatos
Mostrar el registro completo del ítem
PROMISING APPROACH TO REDUCING MALARIA TRANSMISSION BY IVERMECTIN: SPORONTOCIDAL EFFECT AGAINST PLASMODIUM VIVAX IN THE SOUTH AMERICAN VECTORS ANOPHELES AQUASALIS AND ANOPHELES DARLINGI
Autor
Pinilla, Yudi Tatiana
Lopes, Stefanie Costa Pinto
Sampaio, Vanderson Souza
Andrade, Francys S.
Melo, Gisely Cardoso de
Orfanó, Alessandra da Silva
Secundino, Nagila Francinete Costa
Guerra, Maria das Graças Vale Barbosa
Lacerda, Marcus Vinícius Guimarães de
Kobylinski, Kevin C.
Escobedo-Vargas, Karin S.
Lopez-Sifuentes, Victor M.
Stoops, Craig A.
Baldeviano, G. Christian
Tarning, Joel
Vasquez, Gissella M.
Pimenta, Paulo Filemon Paolucci
Monteiro, Wuelton Marcelo
Lopes, Stefanie Costa Pinto
Sampaio, Vanderson Souza
Andrade, Francys S.
Melo, Gisely Cardoso de
Orfanó, Alessandra da Silva
Secundino, Nagila Francinete Costa
Guerra, Maria das Graças Vale Barbosa
Lacerda, Marcus Vinícius Guimarães de
Kobylinski, Kevin C.
Escobedo-Vargas, Karin S.
Lopez-Sifuentes, Victor M.
Stoops, Craig A.
Baldeviano, G. Christian
Tarning, Joel
Vasquez, Gissella M.
Pimenta, Paulo Filemon Paolucci
Monteiro, Wuelton Marcelo
Afiliación
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Fundação Oswaldo Cruz. Instituto de Pesquisas Leônidas & Maria Deane. Manaus, AM, Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Fundação Oswaldo Cruz. Instituto de Pesquisas Leônidas & Maria Deane. Manaus, AM, Brazil
Department of Entomology. Armed Forces Research Institute of Medical Sciences. Bangkok, Thailand.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Mahidol-Oxford Tropical Medicine Research Unit. Faculty of Tropical Medicine. Mahidol University. Bangkok, Thailand/Centre for Tropical Medicine and Global Health.Nuffield Department of Clinical Medicine. University of Oxford. Oxford, United Kingdom.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Fundação Oswaldo Cruz. Instituto de Pesquisas Leônidas & Maria Deane. Manaus, AM, Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Fundação Oswaldo Cruz. Instituto de Pesquisas Leônidas & Maria Deane. Manaus, AM, Brazil
Department of Entomology. Armed Forces Research Institute of Medical Sciences. Bangkok, Thailand.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Mahidol-Oxford Tropical Medicine Research Unit. Faculty of Tropical Medicine. Mahidol University. Bangkok, Thailand/Centre for Tropical Medicine and Global Health.Nuffield Department of Clinical Medicine. University of Oxford. Oxford, United Kingdom.
Department of Entomology. U.S. Naval Medical Research Unit No. 6. Callao, Peru.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Centro Internacional de Pesquisa Clínica em Malária. Manaus, AM, Brazil/Universidade do Estado do Amazonas. Escola Superior de Ciências da Saúde. Manaus, AM, Brazil.
Resumen en ingles
BACKGROUND: The mosquito resistance to the insecticides threatens malaria control efforts, potentially becoming a major public health issue. Alternative methods like ivermectin (IVM) administration to humans has been suggested as a possible vector control to reduce Plasmodium transmission. Anopheles aquasalis and Anopheles darlingi are competent vectors for Plasmodium vivax, and they have been responsible for various malaria outbreaks in the coast of Brazil and the Amazon Region of South America.
METHODS: To determine the IVM susceptibility against P. vivax in An. aquasalis and An. darlingi, ivermectin were mixed in P. vivax infected blood: (1) Powdered IVM at four concentrations (0, 5, 10, 20 or 40 ng/mL). (2) Plasma (0 hours, 4 hours, 1 day, 5, 10 and 14 days) was collected from healthy volunteers after to administer a single oral dose of IVM (200 μg/kg) (3) Mosquitoes infected with P. vivax and after 4 days was provided with IVM plasma collected 4 hours post-treatment (4) P. vivax-infected patients were treated with various combinations of IVM, chloroquine, and primaquine and plasma or whole blood was collected at 4 hours. Seven days after the infective blood meal, mosquitoes were dissected to evaluate oocyst presence. Additionally, the ex vivo effects of IVM against asexual blood-stage P. vivax was evaluated.
RESULTS: IVM significantly reduced the prevalence of An. aquasalis that developed oocysts in 10 to 40 ng/mL pIVM concentrations and plasma 4 hours, 1 day and 5 days. In An. darlingi to 4 hours and 1 day. The An. aquasalis mortality was expressively increased in pIVM (40ng/mL) and plasma 4 hours, 1, 5 10 and 14 days post-intake drug and in An. darlingi only to 4 hours and 1 day. The double fed meal with mIVM by the mosquitoes has a considerable impact on the proportion of infected mosquitoes for 7 days post-feeding. The oocyst infection prevalence and intensity were notably reduced when mosquitoes ingested blood from P. vivax patients that ingested IVM+CQ, PQ+CQ and IVM+PQ+CQ. P. vivax asexual development was considerably inhibited by mIVM at four-fold dilutions.
CONCLUSION: In conclusion, whole blood spiked with IVM reduced the infection rate of P. vivax in An. aquasalis and An. darlingi, and increased the mortality of mosquitoes. Plasma from healthy volunteers after IVM administration affect asexual P. vivax development. These findings support that ivermectin may be used to decrease P. vivax transmission.
Compartir